Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Shares Outstanding (Diluted Average) (2016 - 2025)

INVO Fertility has reported Shares Outstanding (Diluted Average) over the past 15 years, most recently at $1.4 million for Q3 2025.

  • Quarterly Shares Outstanding (Diluted Average) rose 1216.23% to $1.4 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Sep 2025, up 1216.23% year-over-year, with the annual reading at $309539.0 for FY2024, 159.54% up from the prior year.
  • Shares Outstanding (Diluted Average) was $1.4 million for Q3 2025 at INVO Fertility, up from $299114.0 in the prior quarter.
  • Over five years, Shares Outstanding (Diluted Average) peaked at $12.1 million in Q1 2022 and troughed at $85360.0 in Q2 2024.
  • The 5-year median for Shares Outstanding (Diluted Average) is $622507.0 (2023), against an average of $3.3 million.
  • Year-over-year, Shares Outstanding (Diluted Average) plummeted 94.83% in 2023 and then skyrocketed 1216.23% in 2025.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $10.6 million in 2021, then crashed by 94.3% to $606130.0 in 2022, then plummeted by 80.32% to $119264.0 in 2023, then soared by 159.54% to $309539.0 in 2024, then soared by 359.02% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Shares Outstanding (Diluted Average) are $1.4 million (Q3 2025), $299114.0 (Q2 2025), and $1.4 million (Q1 2025).